Clinical observation of Qingdu lotion on patients with high-risk HPV infectio
- Conditions
- Cervical HR-HPV infection
- Registration Number
- ITMCTR2100004828
- Lead Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
1. HPV high-risk type positive;
2. The pathological diagnosis is LSIL and below (including chronic mucosal inflammation, subclinical infection);
3. HR-HPV infection >=6 months;
4. The patient is willing to cooperate with the treatment follow-up and sign the informed consent form;
5. Researchers believe that patients are suitable for participating in clinical trials;
6. The patient did not participate in clinical trials of other drugs, and did not use drugs with similar therapeutic effects as the trial drugs;
7. Female patients between 21-65 years old, regular menstruation or menopause, with a history of sexual life.
1. Acute infection of the external genital area;
2. Lactating women, pregnant women;
3. Patients with systemic chronic wasting disease, severe cardiovascular, liver and kidney disease, hematopoietic system disease;
4. Patients with mental illness;
5. History of drug allergy or allergy;
6. Those who have recently had a birth request;
7. Pathological diagnosis of HSIL.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological reversal rate;HPV negative rate;
- Secondary Outcome Measures
Name Time Method